Age-related findings from the peanut allergy oral immunotherapy study of ar101 for desensitization (palisade) study

Oral immunotherapy (OIT) with AR101 is being developed for treatment of peanut allergy (PA). To better understand the promising phase 3 results, we sought to determine whether there were age-related treatment effects.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: A. Burks, T. Casale, K. Beyer, L. DuToit, S. Jones, J. Hourihane, W. Shreffler, A. Marcantonio, A. Vereda, R. Zawadzki, B. Vickery, D. Adelman Tags: A103 Source Type: research